- Home
- MRNA vs SJM Comparison
MRNA vs SJM Comparison
Compare MRNA & SJM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- SJM
- Stock Information
- Founded
- MRNA 2010
- SJM 1897
- Country
- MRNA United States
- SJM United States
- Employees
- MRNA N/A
- SJM N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- SJM Packaged Foods
- Sector
- MRNA Health Care
- SJM Consumer Staples
- Exchange
- MRNA Nasdaq
- SJM Nasdaq
- Market Cap
- MRNA 9.8B
- SJM 11.6B
- IPO Year
- MRNA 2018
- SJM N/A
- Fundamental
- Price
- MRNA $25.18
- SJM $102.91
- Analyst Decision
- MRNA Hold
- SJM Buy
- Analyst Count
- MRNA 15
- SJM 12
- Target Price
- MRNA $37.15
- SJM $118.27
- AVG Volume (30 Days)
- MRNA 10.8M
- SJM 1.5M
- Earning Date
- MRNA 11-06-2025
- SJM 11-25-2025
- Dividend Yield
- MRNA N/A
- SJM 4.25%
- EPS Growth
- MRNA N/A
- SJM N/A
- EPS
- MRNA N/A
- SJM N/A
- Revenue
- MRNA $3,078,000,000.00
- SJM $8,714,300,000.00
- Revenue This Year
- MRNA N/A
- SJM $5.00
- Revenue Next Year
- MRNA $11.12
- SJM $2.20
- P/E Ratio
- MRNA N/A
- SJM N/A
- Revenue Growth
- MRNA N/A
- SJM 2.54
- 52 Week Low
- MRNA $23.15
- SJM $93.30
- 52 Week High
- MRNA $56.70
- SJM $125.42
- Technical
- Relative Strength Index (RSI)
- MRNA 44.51
- SJM 44.29
- Support Level
- MRNA $24.25
- SJM $100.59
- Resistance Level
- MRNA $29.20
- SJM $103.98
- Average True Range (ATR)
- MRNA 1.50
- SJM 2.28
- MACD
- MRNA -0.13
- SJM 0.01
- Stochastic Oscillator
- MRNA 16.97
- SJM 35.92
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About SJM The J.M. Smucker Company
J.M. Smucker is a packaged food company that primarily sells through the US retail channel (73% of fiscal 2025 revenue came through its retail pet foods, coffee, and frozen handheld/spreads segments), with the remaining share consisting of sweet baked snacks (through the Hostess acquisition) and international (primarily Canada). Retail coffee is its largest category (32% of sales) with brands Folgers and Dunkin'. Pet foods (19% of sales) holds leading brands like Milk-Bone and Meow Mix. Of its remaining, approximately 22% comes from frozen handhelds and spreads, through brands Jif, Smucker's, and Uncrustables. The company acquired Hostess Brands in fiscal 2024 to boost its snack and convenience store presence.